| 1.3 |
3.9 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.9 |
3.6 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.9 |
5.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.9 |
6.2 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.8 |
3.3 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.8 |
2.3 |
GO:0072683 |
T cell extravasation(GO:0072683) |
| 0.7 |
2.1 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.7 |
2.6 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.7 |
1.3 |
GO:2000564 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.6 |
0.6 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.6 |
5.1 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.6 |
3.1 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.6 |
1.9 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.6 |
1.7 |
GO:0043311 |
regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.6 |
0.6 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.5 |
2.1 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 0.5 |
1.5 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.5 |
3.5 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.5 |
3.4 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.5 |
2.4 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.5 |
1.9 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.4 |
1.3 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.4 |
0.9 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.4 |
1.3 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.4 |
0.4 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.4 |
0.4 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.4 |
1.2 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.4 |
0.8 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.4 |
0.4 |
GO:0002605 |
negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
| 0.4 |
2.4 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.4 |
1.6 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.4 |
4.7 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.4 |
1.1 |
GO:0001743 |
optic placode formation(GO:0001743) |
| 0.4 |
2.7 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.4 |
0.4 |
GO:0017143 |
insecticide metabolic process(GO:0017143) |
| 0.4 |
0.4 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.4 |
1.4 |
GO:0042247 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.4 |
0.7 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.3 |
1.7 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.3 |
3.1 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.3 |
1.6 |
GO:1904764 |
negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.3 |
1.0 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.3 |
3.8 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.3 |
1.3 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.3 |
1.3 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.3 |
0.9 |
GO:0080120 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.3 |
1.6 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 0.3 |
0.3 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.3 |
1.2 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.3 |
0.9 |
GO:0014839 |
myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.3 |
1.5 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.3 |
1.2 |
GO:0061349 |
chemoattraction of serotonergic neuron axon(GO:0036517) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
| 0.3 |
2.1 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.3 |
4.9 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.3 |
2.0 |
GO:2000782 |
regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.3 |
3.5 |
GO:0001915 |
negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.3 |
0.9 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.3 |
0.3 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.3 |
1.1 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.3 |
0.8 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.3 |
2.8 |
GO:1902915 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.3 |
0.8 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.3 |
1.1 |
GO:0035546 |
interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
| 0.3 |
2.1 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.3 |
4.4 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.3 |
1.3 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.3 |
0.8 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.3 |
0.8 |
GO:0051086 |
chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.3 |
0.3 |
GO:0061341 |
non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.3 |
1.3 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.3 |
1.0 |
GO:0015883 |
FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.3 |
1.0 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.2 |
1.0 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.2 |
1.7 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 |
1.0 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.2 |
2.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
0.7 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.2 |
1.4 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
0.9 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.2 |
0.7 |
GO:0031106 |
septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 0.2 |
0.7 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.2 |
1.4 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.2 |
0.9 |
GO:1903423 |
positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.2 |
1.9 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.2 |
0.9 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.2 |
0.7 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.2 |
1.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 |
1.1 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.2 |
1.8 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.2 |
0.4 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.2 |
10.8 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.2 |
0.7 |
GO:0090340 |
positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of pancreatic juice secretion(GO:0090187) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.2 |
0.7 |
GO:0070376 |
regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.2 |
0.7 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.2 |
0.9 |
GO:0044053 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.2 |
1.3 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.2 |
0.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
1.5 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.2 |
0.7 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.2 |
0.9 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.2 |
0.9 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
1.1 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 |
0.8 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.2 |
0.6 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.2 |
1.7 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.2 |
0.8 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.2 |
2.1 |
GO:1903003 |
positive regulation of protein deubiquitination(GO:1903003) |
| 0.2 |
0.2 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.2 |
1.4 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.2 |
1.0 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.2 |
1.4 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.2 |
0.6 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.2 |
1.9 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 |
0.4 |
GO:1903598 |
positive regulation of gap junction assembly(GO:1903598) |
| 0.2 |
0.8 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.2 |
0.6 |
GO:0035625 |
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.2 |
0.4 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.2 |
0.6 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.2 |
0.2 |
GO:0030806 |
negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.2 |
0.7 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.2 |
1.7 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 |
0.6 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.2 |
0.5 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.2 |
1.5 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.2 |
0.9 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.2 |
1.1 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.2 |
0.9 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.2 |
0.5 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.2 |
0.7 |
GO:0036071 |
N-glycan fucosylation(GO:0036071) |
| 0.2 |
0.7 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.2 |
0.5 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.2 |
0.5 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 |
0.5 |
GO:0045083 |
negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.2 |
0.7 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
1.2 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.2 |
0.7 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.2 |
0.3 |
GO:0032006 |
regulation of TOR signaling(GO:0032006) |
| 0.2 |
0.5 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.2 |
0.5 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.2 |
1.4 |
GO:0039692 |
single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.2 |
1.9 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
0.5 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.2 |
1.7 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.2 |
0.2 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.2 |
0.5 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.2 |
2.0 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 |
0.3 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.2 |
0.3 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
0.3 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 0.2 |
2.6 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 |
0.6 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.2 |
1.0 |
GO:1900920 |
regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 0.2 |
0.8 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.2 |
0.2 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.2 |
0.5 |
GO:0002513 |
tolerance induction to self antigen(GO:0002513) |
| 0.2 |
0.8 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.2 |
1.4 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 |
0.5 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.2 |
0.2 |
GO:0090402 |
oncogene-induced cell senescence(GO:0090402) |
| 0.2 |
0.9 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 |
0.5 |
GO:1902728 |
positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.2 |
0.6 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.2 |
0.6 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 |
0.3 |
GO:0034445 |
regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 |
1.6 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.1 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 |
0.6 |
GO:0036229 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 |
1.8 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.1 |
0.3 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.1 |
1.0 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.6 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 |
0.3 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 |
1.9 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
1.0 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.1 |
1.3 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
1.7 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.4 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.1 |
0.7 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 |
0.4 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.1 |
0.7 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 |
1.0 |
GO:0061767 |
negative regulation of lung blood pressure(GO:0061767) |
| 0.1 |
1.4 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
1.5 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.4 |
GO:0072737 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.1 |
0.8 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 |
1.1 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
0.7 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
1.3 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.4 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.1 |
0.9 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
0.8 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.7 |
GO:0035936 |
testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.1 |
2.6 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.5 |
GO:0034414 |
tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 0.1 |
1.1 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
2.2 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.1 |
0.5 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
0.1 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.1 |
0.6 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.1 |
0.6 |
GO:0015817 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.1 |
0.5 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.1 |
1.3 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
0.4 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.1 |
1.8 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.1 |
0.4 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.1 |
1.3 |
GO:0045959 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.1 |
0.5 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.1 |
0.4 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 |
0.5 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.1 |
1.8 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.1 |
0.1 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.1 |
0.4 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.1 |
0.9 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.1 |
4.2 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 |
2.2 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
1.6 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
1.4 |
GO:0070424 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.1 |
0.2 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 |
0.4 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 |
0.4 |
GO:0002200 |
somatic diversification of immune receptors(GO:0002200) |
| 0.1 |
0.1 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.1 |
1.0 |
GO:2000232 |
regulation of rRNA processing(GO:2000232) |
| 0.1 |
0.1 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 |
0.7 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.1 |
0.5 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.1 |
0.4 |
GO:0018194 |
N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 |
0.1 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.7 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.7 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 |
0.4 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
1.4 |
GO:0043032 |
positive regulation of macrophage activation(GO:0043032) |
| 0.1 |
0.7 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
1.1 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.1 |
0.9 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.1 |
0.6 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 |
0.1 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
0.1 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 |
0.3 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.1 |
0.5 |
GO:0070987 |
error-free translesion synthesis(GO:0070987) |
| 0.1 |
1.0 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
1.0 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 |
0.5 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 |
1.0 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
1.0 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.1 |
1.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
0.1 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.1 |
0.5 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 |
0.6 |
GO:0032962 |
positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.1 |
0.1 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.1 |
0.7 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.1 |
0.6 |
GO:0045416 |
positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.1 |
0.3 |
GO:1904585 |
response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.1 |
0.7 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.1 |
1.0 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.1 |
0.4 |
GO:1903979 |
negative regulation of microglial cell activation(GO:1903979) |
| 0.1 |
0.1 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.1 |
1.9 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) |
| 0.1 |
0.7 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.1 |
1.0 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.1 |
1.0 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
0.2 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.1 |
0.8 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.1 |
0.9 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 |
0.3 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
0.2 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
0.8 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.3 |
GO:1904875 |
regulation of DNA ligase activity(GO:1904875) |
| 0.1 |
1.3 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
0.3 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.1 |
0.1 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 |
1.1 |
GO:0060318 |
regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
| 0.1 |
0.4 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.1 |
0.4 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 |
0.5 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.1 |
1.2 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 |
0.2 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.1 |
0.3 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 |
0.4 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.1 |
0.4 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.3 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.1 |
1.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.6 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.8 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
2.1 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
0.3 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
2.0 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.8 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 0.1 |
1.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.2 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 |
0.7 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.4 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.1 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.1 |
0.1 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 |
0.5 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 |
0.3 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 |
0.6 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.4 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.8 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.6 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.1 |
0.3 |
GO:0006117 |
acetaldehyde metabolic process(GO:0006117) |
| 0.1 |
0.4 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.4 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 |
0.6 |
GO:0034351 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 |
0.7 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.1 |
0.3 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.3 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.1 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 |
0.1 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 0.1 |
0.1 |
GO:0048372 |
lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.1 |
0.4 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.1 |
0.8 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.4 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.8 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
3.2 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.8 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.1 |
0.2 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.1 |
2.3 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
0.4 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 |
0.1 |
GO:1902741 |
type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.1 |
0.9 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
0.3 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.1 |
0.6 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 |
2.0 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
2.3 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
0.3 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 |
0.3 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.1 |
2.1 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.1 |
0.3 |
GO:0072396 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.1 |
0.5 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.2 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.1 |
0.2 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
0.3 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.1 |
4.5 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
0.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.2 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.1 |
0.4 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.7 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.1 |
0.7 |
GO:0061085 |
regulation of histone H3-K27 methylation(GO:0061085) |
| 0.1 |
0.2 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.5 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.5 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 |
1.0 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
1.3 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.2 |
GO:0031098 |
stress-activated protein kinase signaling cascade(GO:0031098) |
| 0.1 |
0.6 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
0.8 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.1 |
0.1 |
GO:0051495 |
positive regulation of cytoskeleton organization(GO:0051495) |
| 0.1 |
0.2 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.1 |
0.3 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
4.1 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.1 |
0.4 |
GO:0090670 |
RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
| 0.1 |
0.2 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.1 |
0.3 |
GO:0032434 |
regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
| 0.1 |
0.3 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.1 |
0.3 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.2 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.1 |
0.7 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.5 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
0.6 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
0.7 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 |
0.2 |
GO:0070945 |
neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.1 |
0.2 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 0.1 |
0.1 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 |
0.6 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
4.6 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 |
1.8 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.1 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.1 |
1.0 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.1 |
0.2 |
GO:0001781 |
neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.1 |
0.1 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.1 |
0.2 |
GO:2001201 |
regulation of anagen(GO:0051884) regulation of transforming growth factor-beta secretion(GO:2001201) |
| 0.1 |
0.2 |
GO:1902750 |
negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.1 |
1.6 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
2.1 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
1.6 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.1 |
1.7 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.2 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.1 |
0.6 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.4 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
1.4 |
GO:0015886 |
heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
| 0.1 |
0.7 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.6 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 |
0.2 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.1 |
0.5 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.9 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 |
0.2 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.2 |
GO:0035281 |
pre-miRNA export from nucleus(GO:0035281) |
| 0.1 |
0.3 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.1 |
0.2 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.1 |
1.4 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 |
0.2 |
GO:0016260 |
selenocysteine metabolic process(GO:0016259) selenocysteine biosynthetic process(GO:0016260) |
| 0.1 |
0.1 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.1 |
0.2 |
GO:0035947 |
regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
| 0.1 |
5.8 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.1 |
0.4 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
0.2 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
3.5 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.5 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.1 |
0.1 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.1 |
0.5 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.1 |
0.2 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.6 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.2 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 |
0.4 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
0.4 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
| 0.1 |
0.3 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.1 |
0.5 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.1 |
1.3 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
0.1 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 |
1.2 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.1 |
0.7 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.4 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.1 |
0.4 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.4 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 |
0.2 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.1 |
0.3 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
1.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.7 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.1 |
0.6 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 |
0.4 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.1 |
0.1 |
GO:0002476 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.1 |
1.1 |
GO:2000674 |
regulation of type B pancreatic cell apoptotic process(GO:2000674) |
| 0.1 |
0.4 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.1 |
0.4 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 0.1 |
0.3 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.1 |
0.2 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 |
0.4 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.1 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 |
0.1 |
GO:1904744 |
regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 |
0.3 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.1 |
0.2 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.1 |
1.0 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
0.4 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.1 |
0.6 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.4 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 |
0.5 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.1 |
0.4 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.1 |
0.4 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.1 |
0.3 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.1 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.1 |
1.0 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
0.4 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.1 |
0.5 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 |
3.8 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
1.2 |
GO:0070586 |
cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.1 |
5.9 |
GO:0006521 |
regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.1 |
0.1 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
0.1 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 |
0.4 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.1 |
1.8 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.1 |
GO:0006563 |
L-serine metabolic process(GO:0006563) |
| 0.1 |
0.7 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
0.1 |
GO:2000779 |
regulation of double-strand break repair(GO:2000779) |
| 0.1 |
0.5 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
1.3 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
0.1 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 |
0.2 |
GO:0070922 |
small RNA loading onto RISC(GO:0070922) |
| 0.1 |
0.7 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 |
4.8 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.1 |
0.7 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.2 |
GO:1901222 |
regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.1 |
0.4 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.3 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 |
0.3 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
0.2 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 |
0.8 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.5 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
0.3 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.2 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.1 |
0.1 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 |
0.5 |
GO:0097466 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.1 |
0.1 |
GO:0006408 |
snRNA export from nucleus(GO:0006408) |
| 0.1 |
0.1 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.5 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
0.2 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.1 |
0.4 |
GO:0033504 |
floor plate development(GO:0033504) |
| 0.1 |
0.3 |
GO:0036473 |
cell death in response to oxidative stress(GO:0036473) |
| 0.1 |
0.2 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 |
0.3 |
GO:0046092 |
deoxycytidine metabolic process(GO:0046092) |
| 0.1 |
0.2 |
GO:0003193 |
pulmonary valve formation(GO:0003193) atrial ventricular junction remodeling(GO:0003294) foramen ovale closure(GO:0035922) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.1 |
1.0 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 |
0.4 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
4.4 |
GO:0010833 |
telomere maintenance via telomere lengthening(GO:0010833) |
| 0.1 |
0.2 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
0.4 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) DNA strand elongation(GO:0022616) |
| 0.1 |
1.3 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 |
3.0 |
GO:0071431 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.6 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.1 |
0.1 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.1 |
1.0 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.2 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.1 |
0.2 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.1 |
0.5 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.1 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 0.1 |
1.3 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
0.9 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.2 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.1 |
0.5 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.1 |
0.3 |
GO:0061015 |
RNA import into nucleus(GO:0006404) snRNA transport(GO:0051030) snRNA import into nucleus(GO:0061015) |
| 0.1 |
0.5 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.2 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.4 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
0.3 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
1.1 |
GO:0021924 |
cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.1 |
2.4 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
1.4 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 |
0.6 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.1 |
2.4 |
GO:0035666 |
TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.1 |
0.3 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.1 |
0.2 |
GO:1904995 |
negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 |
0.2 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.2 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 |
0.2 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.1 |
0.6 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
0.1 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 |
0.2 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
0.2 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
1.2 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.3 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.1 |
GO:1904037 |
positive regulation of epithelial cell apoptotic process(GO:1904037) positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
0.3 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.1 |
0.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.1 |
GO:0090034 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 |
0.2 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.3 |
GO:0030805 |
regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.1 |
0.3 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.4 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
0.3 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
0.6 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
0.1 |
GO:1902903 |
regulation of fibril organization(GO:1902903) |
| 0.1 |
0.3 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
0.1 |
GO:0061156 |
pulmonary artery morphogenesis(GO:0061156) |
| 0.1 |
0.5 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.1 |
0.1 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 |
0.1 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 |
0.3 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.1 |
1.0 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
1.6 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.3 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.1 |
0.1 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 |
0.1 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.1 |
0.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
0.4 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.1 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 |
0.1 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 |
0.3 |
GO:1903299 |
regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
| 0.1 |
0.3 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.1 |
0.4 |
GO:0040023 |
establishment of nucleus localization(GO:0040023) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.5 |
GO:0015781 |
nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.1 |
0.3 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 |
0.4 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.1 |
0.3 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
0.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
1.0 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
1.0 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.4 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.1 |
1.4 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.0 |
0.3 |
GO:0044126 |
regulation of growth of symbiont in host(GO:0044126) |
| 0.0 |
0.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
0.7 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.0 |
0.6 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 |
0.2 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.0 |
0.2 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.0 |
0.1 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.0 |
0.3 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.2 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.0 |
0.2 |
GO:1900248 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.0 |
0.1 |
GO:0042489 |
negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.0 |
0.0 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 |
0.4 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 |
0.1 |
GO:0015729 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.0 |
0.8 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.8 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.0 |
0.2 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.0 |
0.5 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 |
0.5 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.0 |
0.2 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 |
0.5 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 |
0.3 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.0 |
0.2 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.0 |
0.4 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
0.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.0 |
0.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.0 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 0.0 |
0.2 |
GO:1902378 |
vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) renal artery morphogenesis(GO:0061441) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.0 |
0.0 |
GO:0051461 |
corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.0 |
0.8 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.0 |
0.0 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.0 |
0.2 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.0 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.4 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.0 |
0.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.0 |
0.2 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.0 |
0.4 |
GO:0043092 |
L-amino acid import(GO:0043092) |
| 0.0 |
1.2 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.2 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.2 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.0 |
0.4 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 |
0.2 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.0 |
0.3 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.0 |
0.3 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.0 |
0.2 |
GO:1903352 |
L-ornithine transmembrane transport(GO:1903352) |
| 0.0 |
0.9 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.0 |
0.3 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.0 |
0.1 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.0 |
0.4 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.4 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.5 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.6 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.2 |
GO:0097045 |
phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.0 |
0.4 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.9 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.1 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.4 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.0 |
0.2 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.0 |
0.0 |
GO:0002368 |
B cell cytokine production(GO:0002368) |
| 0.0 |
0.0 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.0 |
0.1 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 |
0.6 |
GO:2000352 |
negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.0 |
0.2 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.4 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
1.6 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.0 |
1.7 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
2.3 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
0.2 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.0 |
0.6 |
GO:0043970 |
histone H3-K9 acetylation(GO:0043970) |
| 0.0 |
0.3 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.0 |
0.4 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.0 |
0.3 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.0 |
GO:0098911 |
regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
| 0.0 |
0.2 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.0 |
0.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.0 |
0.2 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.0 |
0.7 |
GO:0035729 |
cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.0 |
0.2 |
GO:0046021 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 0.0 |
0.2 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.0 |
0.1 |
GO:0038044 |
transforming growth factor-beta secretion(GO:0038044) |
| 0.0 |
0.9 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 |
0.4 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.0 |
0.3 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.0 |
0.4 |
GO:0034311 |
sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
| 0.0 |
0.9 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 |
1.0 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
2.2 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 |
0.0 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.0 |
3.5 |
GO:0090263 |
positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 |
0.3 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.1 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.0 |
0.1 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.0 |
0.2 |
GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
| 0.0 |
0.1 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 0.0 |
0.2 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.0 |
0.6 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.6 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 |
0.4 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.0 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.0 |
0.4 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 |
0.3 |
GO:0070670 |
response to interleukin-4(GO:0070670) |
| 0.0 |
0.4 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.3 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
0.2 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.0 |
0.2 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.0 |
0.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.2 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.0 |
0.3 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
0.2 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.0 |
0.1 |
GO:0050856 |
regulation of T cell receptor signaling pathway(GO:0050856) |
| 0.0 |
0.6 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.0 |
0.0 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.0 |
0.2 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.0 |
0.7 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.0 |
0.1 |
GO:0003056 |
regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.0 |
0.3 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 |
0.7 |
GO:0009620 |
response to fungus(GO:0009620) |
| 0.0 |
0.1 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.1 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.0 |
0.1 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.0 |
0.4 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.3 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 |
0.0 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.0 |
0.1 |
GO:0003413 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.0 |
0.2 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.0 |
0.7 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.0 |
0.3 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.0 |
GO:0042559 |
folic acid-containing compound biosynthetic process(GO:0009396) pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.0 |
0.6 |
GO:0051769 |
nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
| 0.0 |
0.3 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 |
0.6 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.0 |
0.4 |
GO:0045995 |
regulation of embryonic development(GO:0045995) |
| 0.0 |
0.0 |
GO:0072025 |
distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.0 |
0.3 |
GO:0051099 |
positive regulation of binding(GO:0051099) |
| 0.0 |
0.0 |
GO:0002545 |
chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.0 |
0.7 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.0 |
1.2 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.0 |
0.3 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.0 |
0.1 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.0 |
0.1 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 |
0.2 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.0 |
0.4 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.5 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.0 |
0.0 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.0 |
0.3 |
GO:2001205 |
negative regulation of osteoclast development(GO:2001205) |
| 0.0 |
0.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.1 |
GO:0061197 |
fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) |
| 0.0 |
0.2 |
GO:0036018 |
cellular response to erythropoietin(GO:0036018) |
| 0.0 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.0 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 |
0.7 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.0 |
0.3 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.0 |
0.3 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.0 |
0.1 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.0 |
0.1 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 |
0.2 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.0 |
0.1 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.0 |
0.0 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.0 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.2 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.0 |
0.1 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
| 0.0 |
0.3 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.2 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 |
0.2 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 |
0.3 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 |
0.7 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 |
0.7 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.0 |
0.6 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.5 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.0 |
0.1 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.0 |
0.2 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.0 |
0.5 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.0 |
GO:0060491 |
regulation of cell projection assembly(GO:0060491) |
| 0.0 |
0.1 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.1 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 |
1.4 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.0 |
0.1 |
GO:1904953 |
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.0 |
0.9 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.0 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.0 |
0.0 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.0 |
0.4 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.0 |
0.2 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 |
0.1 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.0 |
0.4 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 |
0.1 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.0 |
0.1 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.0 |
0.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.0 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.6 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.0 |
0.6 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.0 |
0.1 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.0 |
0.2 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 |
0.4 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.3 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.6 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.0 |
0.2 |
GO:0002551 |
mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) |
| 0.0 |
0.1 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.0 |
0.2 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.4 |
GO:0032204 |
regulation of telomere maintenance(GO:0032204) |
| 0.0 |
0.4 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.0 |
0.1 |
GO:0051177 |
meiotic sister chromatid cohesion(GO:0051177) meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.0 |
0.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.0 |
0.1 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.0 |
0.4 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.0 |
0.1 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.0 |
0.1 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.0 |
0.4 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.0 |
0.1 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.0 |
0.2 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.0 |
0.8 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.6 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.1 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.0 |
0.1 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.0 |
0.6 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.0 |
0.1 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.0 |
0.7 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.2 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.1 |
GO:0060849 |
radial pattern formation(GO:0009956) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.0 |
0.2 |
GO:0061365 |
positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.0 |
0.1 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 |
0.5 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.3 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.1 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.0 |
0.1 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.0 |
0.3 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.1 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.0 |
0.5 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.0 |
0.2 |
GO:0008356 |
asymmetric cell division(GO:0008356) |
| 0.0 |
0.0 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.0 |
0.1 |
GO:0051169 |
nuclear transport(GO:0051169) |
| 0.0 |
0.3 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.1 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.0 |
0.2 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.1 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.0 |
0.3 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.1 |
GO:0038111 |
interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.0 |
0.1 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.0 |
GO:0015824 |
proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
| 0.0 |
0.3 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.0 |
0.1 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.6 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 |
0.5 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.0 |
0.1 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 |
0.1 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.0 |
0.6 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.1 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
| 0.0 |
0.0 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.0 |
0.1 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.0 |
0.1 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.0 |
0.3 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.0 |
0.1 |
GO:0035878 |
nail development(GO:0035878) |
| 0.0 |
0.1 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.0 |
0.1 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.0 |
0.2 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.0 |
0.0 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.0 |
0.2 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.3 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.0 |
0.4 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.0 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.0 |
0.3 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.0 |
0.2 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.0 |
GO:0002584 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
| 0.0 |
0.2 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.0 |
0.3 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.1 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.1 |
GO:0070103 |
regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
| 0.0 |
0.1 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.0 |
0.2 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.0 |
0.2 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.1 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.0 |
0.6 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.4 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.0 |
0.3 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.2 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.0 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.3 |
GO:0033081 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.2 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 |
0.0 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.0 |
0.1 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.0 |
0.1 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.1 |
GO:1903515 |
regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.0 |
0.0 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.1 |
GO:0090158 |
endoplasmic reticulum membrane organization(GO:0090158) |
| 0.0 |
0.3 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.0 |
0.1 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.1 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.0 |
0.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.1 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.0 |
0.1 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.1 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.0 |
0.3 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.0 |
0.2 |
GO:0002759 |
regulation of antimicrobial humoral response(GO:0002759) |
| 0.0 |
0.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.2 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.0 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
| 0.0 |
0.1 |
GO:2001044 |
regulation of integrin-mediated signaling pathway(GO:2001044) |
| 0.0 |
0.4 |
GO:0045927 |
positive regulation of growth(GO:0045927) |
| 0.0 |
0.9 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.4 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.0 |
0.1 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 |
0.0 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 |
0.7 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 |
0.1 |
GO:0042267 |
natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 |
0.2 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 |
0.1 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.0 |
0.1 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.0 |
0.0 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.0 |
0.4 |
GO:0043691 |
reverse cholesterol transport(GO:0043691) |
| 0.0 |
0.1 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
2.2 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.1 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.1 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.4 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.1 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 |
0.6 |
GO:0072678 |
T cell migration(GO:0072678) |
| 0.0 |
0.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.1 |
GO:0060161 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) positive regulation of dopamine receptor signaling pathway(GO:0060161) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.0 |
1.1 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.0 |
0.0 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.0 |
0.0 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
1.0 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
1.5 |
GO:0051168 |
nuclear export(GO:0051168) |
| 0.0 |
0.1 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.0 |
0.2 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.0 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.0 |
0.1 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.0 |
0.2 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.0 |
0.1 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.0 |
0.0 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.0 |
0.6 |
GO:0051350 |
negative regulation of lyase activity(GO:0051350) |
| 0.0 |
0.7 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.2 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 |
0.1 |
GO:2000697 |
negative regulation by virus of viral protein levels in host cell(GO:0046725) kidney mesenchymal cell proliferation(GO:0072135) metanephric mesenchymal cell proliferation involved in metanephros development(GO:0072136) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
| 0.0 |
1.6 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
| 0.0 |
0.2 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.1 |
GO:0046851 |
negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.0 |
0.2 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.0 |
0.1 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.0 |
0.0 |
GO:0032097 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.0 |
0.1 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
0.0 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.0 |
0.1 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 |
0.2 |
GO:0003094 |
glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 0.0 |
0.1 |
GO:0015942 |
formate metabolic process(GO:0015942) |
| 0.0 |
0.1 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 |
0.3 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.0 |
0.1 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.0 |
0.3 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.0 |
0.1 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.0 |
0.1 |
GO:1903506 |
regulation of nucleic acid-templated transcription(GO:1903506) |
| 0.0 |
0.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.1 |
GO:1904892 |
regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
| 0.0 |
0.6 |
GO:0050771 |
negative regulation of axonogenesis(GO:0050771) |
| 0.0 |
0.4 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.3 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.0 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
| 0.0 |
0.1 |
GO:0001756 |
somitogenesis(GO:0001756) |
| 0.0 |
0.1 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.0 |
0.0 |
GO:1904528 |
positive regulation of microtubule binding(GO:1904528) |
| 0.0 |
0.2 |
GO:1902041 |
regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) |
| 0.0 |
0.0 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.0 |
0.1 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.0 |
0.1 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.1 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.0 |
0.1 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.0 |
0.1 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) |
| 0.0 |
0.2 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.0 |
0.1 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 |
0.3 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.3 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.0 |
0.0 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.0 |
0.0 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.0 |
0.1 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 |
0.3 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 |
0.1 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.0 |
0.0 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.0 |
0.4 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.0 |
0.4 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.9 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.0 |
0.1 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.0 |
0.2 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.0 |
0.1 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.3 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
0.0 |
GO:0045343 |
negative regulation of interleukin-13 production(GO:0032696) MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.0 |
0.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.0 |
GO:0019827 |
stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
| 0.0 |
0.2 |
GO:0001825 |
blastocyst formation(GO:0001825) |
| 0.0 |
0.1 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.0 |
0.2 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 |
0.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 |
0.1 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.0 |
0.4 |
GO:0071174 |
mitotic spindle checkpoint(GO:0071174) |
| 0.0 |
0.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.0 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 |
0.7 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.0 |
0.6 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.2 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.2 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.0 |
0.3 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.0 |
0.5 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.4 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.0 |
0.1 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.0 |
0.0 |
GO:0006349 |
regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.0 |
0.6 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.1 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.1 |
GO:0018023 |
peptidyl-lysine trimethylation(GO:0018023) |
| 0.0 |
0.5 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.0 |
0.1 |
GO:2001026 |
regulation of endothelial cell chemotaxis(GO:2001026) |
| 0.0 |
0.2 |
GO:0048247 |
lymphocyte chemotaxis(GO:0048247) |
| 0.0 |
0.1 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 0.0 |
0.1 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.0 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
0.2 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.1 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.0 |
0.1 |
GO:0002369 |
T cell cytokine production(GO:0002369) |
| 0.0 |
0.3 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 |
0.1 |
GO:0002374 |
cytokine secretion involved in immune response(GO:0002374) |
| 0.0 |
0.1 |
GO:0003281 |
ventricular septum development(GO:0003281) |
| 0.0 |
0.2 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.0 |
0.1 |
GO:0019054 |
modulation by virus of host process(GO:0019054) |
| 0.0 |
0.1 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.0 |
1.8 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.2 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 |
0.1 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 |
0.0 |
GO:0033007 |
negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
| 0.0 |
0.1 |
GO:0002396 |
MHC protein complex assembly(GO:0002396) MHC class II protein complex assembly(GO:0002399) |
| 0.0 |
0.2 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.0 |
0.0 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.0 |
0.0 |
GO:0071223 |
response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
| 0.0 |
0.1 |
GO:0002304 |
gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.0 |
0.3 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.0 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.1 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.0 |
0.0 |
GO:0051890 |
regulation of cardioblast differentiation(GO:0051890) |
| 0.0 |
0.0 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.0 |
0.1 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.5 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.0 |
0.1 |
GO:1904049 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) negative regulation of long-term synaptic potentiation(GO:1900272) regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.0 |
0.1 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.0 |
0.2 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.0 |
0.2 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.1 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
0.1 |
GO:0050931 |
pigment cell differentiation(GO:0050931) |
| 0.0 |
0.1 |
GO:1902306 |
negative regulation of sodium ion transmembrane transport(GO:1902306) |
| 0.0 |
0.1 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 |
0.1 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.1 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.0 |
0.1 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.0 |
0.1 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.0 |
1.1 |
GO:0007586 |
digestion(GO:0007586) |
| 0.0 |
0.1 |
GO:0052696 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 |
0.0 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.0 |
0.0 |
GO:0008215 |
spermine metabolic process(GO:0008215) |
| 0.0 |
0.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.0 |
0.0 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.0 |
0.0 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.0 |
0.0 |
GO:0002774 |
Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.0 |
0.6 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.0 |
0.3 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.0 |
0.1 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.0 |
0.2 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.1 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.0 |
0.0 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.1 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.0 |
0.0 |
GO:1903204 |
neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.0 |
0.1 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.0 |
0.1 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
0.0 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
0.4 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.8 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.0 |
0.1 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.0 |
0.1 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.0 |
0.0 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.0 |
0.0 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 |
0.1 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
0.0 |
GO:0044144 |
modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.0 |
0.1 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.0 |
GO:0009624 |
response to nematode(GO:0009624) |
| 0.0 |
0.0 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.0 |
0.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.0 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.2 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.0 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.0 |
0.0 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.0 |
0.2 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.0 |
0.2 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 |
0.0 |
GO:0010626 |
regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.0 |
1.1 |
GO:0030010 |
establishment of cell polarity(GO:0030010) |
| 0.0 |
0.1 |
GO:0060677 |
ureteric bud elongation(GO:0060677) |
| 0.0 |
0.1 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.0 |
0.0 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.0 |
0.1 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.0 |
0.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.0 |
0.0 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.0 |
0.3 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
0.1 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.1 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.0 |
0.7 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 |
0.0 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.0 |
0.4 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.0 |
GO:0033488 |
cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.0 |
0.2 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
